Search

Dr Reddy's Laboratories Ltd-ADR

Atidarymo kaina

SektoriusSveikatos priežiūra

11.84 -1

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

11.94

Max

12.01

Pagrindiniai rodikliai

By Trading Economics

Pajamos

2.1B

4.3B

Pardavimai

4.9B

81B

P/E

Sektoriaus vid.

29.585

56.659

Pelnas, tenkantis vienai akcijai

0.06

Dividendų pajamingumas

0.68

Pelno marža

5.356

Darbuotojai

27,527

EBITDA

-5.8B

3B

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+36.09% upside

Dividendai

By Acuity

Dividendų pajamingumas

Sektoriaus vid.

0.68%

2.18%

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-330M

10B

Ankstesnė atidarymo kaina

12.84

Ankstesnė uždarymo kaina

11.84

Naujienos nuotaikos

By Acuity

50%

50%

132 / 339 reitingas Healthcare

Dr Reddy's Laboratories Ltd-ADR Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-09-05 00:05; UTC

News

Illumina Inc will join the S&P 500 on September 21, 2026. Shares are advancing in after-market hours following the announcement.

2026-09-05 00:05; UTC

News

Ionis Pharmaceuticals shares are lower in after-market hours following Novartis' announcement that the pelacarsen Phase 3 study did not meet its primary endpoint.

2026-09-05 00:01; UTC

News

Royalty Pharma PLC shares fell in after-market hours following the failed Phase 3 trial of pelacarsen, impacting its funding agreement with Ionis.

2026-09-05 00:01; UTC

Social Media
News

NIO shares are higher in after-market hours following a 69.1% revenue increase to approximately $4.74 billion and improved vehicle deliveries.

2026-09-05 00:01; UTC

News

Bloom Energy Corp will join the S&P 500 on September 21, 2026, boosting investor visibility. Shares are trading higher in after-market hours.

2026-09-05 00:01; UTC

News

Shares lower in after-market trading; Roth Capital targets $48.00.

2026-09-05 00:00; UTC

News

Campbell's Co shares increased in after-market trading following workforce cuts and price hikes aimed at improving profitability.

2026-09-05 00:00; UTC

News

DocuSign Inc reported stronger-than-expected second-quarter results but is trading lower in after-market hours, reflecting valuation concerns amid rising Treasury yields.

2026-09-04 23:40; UTC

News

DocuSign Inc. reported strong second-quarter results and raised guidance, yet shares are trading lower in after-market hours amid valuation concerns and economic context.

2026-09-04 23:35; UTC

News

AAP shares lower in after-market hours on analyst rating updates.

2026-09-04 23:27; UTC

News

Photronics Inc shares traded lower in after-market hours amid a securities class action lawsuit alleging fraud related to its product pipeline and demand stability.

2026-09-04 23:20; UTC

News

Monster Beverage appoints Matthew S. Burroughs as Chief Accounting Officer and Deputy CFO, with shares rising in after-market trading.

2026-09-04 23:10; UTC

News

Northrop Grumman was awarded a $508.49 million contract for flight test support by the U.S. Department of Defense, shares trading higher in after-market hours.

2026-09-04 23:05; UTC

News

Pomerantz LLP filed a class action lawsuit against Replimune Group Inc for alleged securities fraud, contributing to a decline in shares during after-market hours.

2026-09-04 23:02; UTC

News

Illumina Inc will join the S&P 500 index effective September 21, 2026, following an announcement by Dow Jones Indices. Shares are trading higher after the news.

2026-09-04 23:02; UTC

Social Media
News

Star Bulk Carriers announced a parallel listing on Euronext Athens and an equity offering. Shares are lower in after-market hours following the news.

2026-09-04 23:02; UTC

News

Ionis Pharmaceuticals shares declined in after-market trading following Novartis' announcement of the failed pelacarsen Phase 3 study to reduce cardiovascular events.

2026-09-04 23:00; UTC

News

Bloom Energy shares are higher in after-market trading following its inclusion in the S&P 500, effective September 21, 2026.

2026-09-04 23:00; UTC

News

FirstEnergy shares rise in after-market trading following Potomac Edison's $52.8 million rate adjustment proposal to enhance electric system reliability in Maryland.

2026-09-04 23:00; UTC

News

Campbell's Co announced a restructuring plan, cutting 13% of salaried jobs and closing two plants. Shares are trading higher in after-market hours.

2026-09-04 22:51; UTC

Correlated Moves
News

Shares rose in after-market trading amid strength in oil sector.

2026-09-04 20:08; UTC

News

Planet Fitness Inc. is facing a securities class action lawsuit alleging misleading statements on customer growth, contributing to a decline in its stock during Friday's session.

2026-09-04 20:08; UTC

News
Correlated Moves

Marten Transport Ltd shares are higher, supported by a broader transportation sector rally and an amended credit facility increasing the letters-of-credit sublimit to $50 million.

2026-09-04 20:08; UTC

News

Jefferies Financial Group's shares are higher as it maintains "buy" ratings and raises price targets for several banks, including Barclays and Lloyds.

2026-09-04 20:08; UTC

News

El Pollo Loco Holdings to participate in two investor conferences this month. Shares are trading higher, reflecting positive sentiment despite earlier session pullback.

2026-09-04 20:08; UTC

News

Intuitive Surgical shares declined to $365.21, marking a four-week low. Ongoing market challenges contributed to the stock's downward movement during the session.

2026-09-04 20:08; UTC

News
Social Media
Macro Event

McDonald's shares hit a 52-week low amid ongoing challenges, including high menu prices like $15 for an Egg McMuffin, reflecting a broader market decline.

2026-09-04 20:08; UTC

News

OrthoPediatrics Corp shares are lower amid broader market declines and selling pressure following a strong jobs report. A major shareholder's recent sale adds to negative sentiment.

2026-09-04 20:08; UTC

Social Media
Macro Event
News
Correlated Moves

Intel shares are higher as demand for CPUs surges, driven by AI workloads. Despite a price target cut to $92, investor sentiment remains positive.

2026-09-04 20:08; UTC

News
Correlated Moves
Social Media

Advanced Micro Devices is rising as AI demand boosts projections for its EPYC CPUs, aided by partnerships like Microsoft’s Project Zenith.

Akcijų palyginimas

Kainos pokytis

Dr Reddy's Laboratories Ltd-ADR Prognozė

Kainos tikslas

By TipRanks

36.09% į viršų

12 mėnesių prognozė

Vidutinis 16.29 USD  36.09%

Aukščiausias 16.295 USD

Žemiausias 16.295 USD

Remiantis 1 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Dr Reddy's Laboratories Ltd-ADR kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

1 ratings

1

Pirkti

0

Laikyti

0

Parduoti

Rinkos nuotaikos

By Acuity

132 / 339 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Vidutinis

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Dr Reddy's Laboratories Ltd-ADR

Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segments. The company's Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations, as well as engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids in accordance with the specific customer requirements. The Others segment engages in developing therapies in the fields of oncology and inflammation; research and development of differentiated formulations; and provides digital healthcare and information technology enabled business support services. The company offers its products for various therapeutic categories primarily include gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.
help-icon Live chat